(Q52991088)

English

Standardized uptake value on positron emission tomography/computed tomography predicts prognosis in patients with locally advanced pancreatic cancer.

scientific article published on 9 September 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/26350284

Standardized uptake value on positron emission tomography/computed tomography predicts prognosis in patients with locally advanced pancreatic cancer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/26350284

1 reference

based on heuristic

inferred from title

author name string

Si-Liang Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/26350284

Shuo Cao

2

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/26350284

Yu-Nan Sun

3

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/26350284

Rong Wu

4

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/26350284

Feng Chi

5

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/26350284

Mei-Yue Tang

6

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/26350284

Xue-Ying Jin

7

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/26350284

Xiao-Dong Chen

8

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/26350284

publication date

9 September 2015

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/26350284

Abdominal Imaging

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/26350284

40

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/26350284

8

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/26350284

3117-3121

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/26350284

Pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

Pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

Radiotherapy technical considerations in the management of locally advanced pancreatic cancer: American-French consensus recommendations

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

A systematic review and meta-analysis of survival and surgical outcomes following neoadjuvant chemoradiotherapy for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

PET/CT of cancer patients: part 1, pancreatic neoplasms

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

Impact of initial PET/CT staging in terms of clinical stage, management plan, and prognosis in 592 patients with non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

Advances in biomarker research for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

Cytokeratin 19-fragments (CYFRA 21-1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

Diagnostic accuracy of K-ras mutation for pancreatic carcinoma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9.

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

18-Fluorodeoxyglucose positron emission tomography in predicting survival of patients with pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

Predictive value of maximum standardized uptake value (SUVmax) on 18F-FDG PET/CT in patients with locally advanced or metastatic pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

Diagnostic value of preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 in colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

Decline in CA19-9 during chemotherapy predicts survival in four independent cohorts of patients with inoperable bile duct cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

The prognostic and predictive value of serum CA19.9 in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

Pretreatment carbohydrate antigen 19-9 level indicates tumor response, early distant metastasis, overall survival, and therapeutic selection in localized and unresectable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS00261-015-0544-3

21 January 2018

Identifiers

10.1007/S00261-015-0544-3

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/26350284

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/26350284

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52991088&oldid=1514311929"